Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dendritic Cell Therapy, Cryoablation, and Pembrolizumab in Non-Hodgkin Lymphoma
NCT03035331Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2017
- Primary completion
- Jan 2022
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of TriMix-DC in non-Hodgkin lymphoma (NHL), sponsored by Mayo Clinic. Started Aug 2017; status: completed.
02
Drugs
TriMix-DC
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT03035331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03035331.